Micro-sized cold atmospheric plasma (µCAP) has been developed to expand the applications of CAP in cancer therapy. In this paper, µCAP devices with different nozzle lengths were applied to investigate effects on both brain (glioblastoma U87) and breast (MDA-MB-231) cancer cells.
Introduction
Cold atmospheric plasma (CAP) has been proposed as a novel therapeutic method for anticancer treatment, which can be applied to living tissues and cells 1, 2 . CAP is a partially ionized gas that contain charge particles, reactive oxygen and nitrogen species (ROS and RNS), excited atoms, free radicals, UV photons, electric field, etc 3, 4 . ROS and RNS, combined or independently, are well known to initiate different signaling pathways in cells and to promote oxidative stress 5, 6 . Plasmainduced biological effects include damage lips, proteins, DNA, and induce apoptosis through plasma-generated ROS and RNS [7] [8] [9] [10] . Moreover, many studies have reported both in vivo and vitro that plasma is a possible adjunct treatment in oncology as well as killing achieved for various types of cancers such as glioblastoma, breast cancer, bladder carcinoma, cervical carcinoma, skin carcinoma, pancreatic carcinoma, lung carcinoma, colon carcinoma, gastric carcinoma, melanoma and hepatocellular carcinoma [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
In plasma medicine, jet plasma, corona discharge, and dielectric barrier discharge (DBD) have been used 28 . These types of plasma can be directly applied to skin cancers, while they are not applicable for more systemic cancer treatment. Some studies investigated the plasma device in the micro-sized to conduct the plasma species to the living animals 29 . However, their device just applied to xenografts tumors not systemic cancer treatment. Moreover, delivery of the plasma species is crucial to suppress tumor growth and assess efficiency of micro-sized plasma device.
Hence, this study aims to design micro-sized cold atmospheric plasma devices with different lengths of nozzle in order to enhance delivery of reactive species and evaluate the efficiency of these devices on cancer therapy. Fig. 1 shows the potential applications of µCAP for brain and breast tumors in the future. and a grounded outer electrode wrapped around the outside of a quartz tube (10 mm) as shown in Fig. 2b . The electrodes were connected to the secondary output of the high voltage transformer.
The peak-peak voltage was approximately 8 kV and the frequency of the discharge was around 16
kHz (upper right in Fig. 2a ). The secondary output of high voltage transformer was connected to the first input. At the end of a quartz tube, a 275 ± 5 m inner diameter capillary tube (stainless steel) with 20 or 60 mm length was attached and insulated by epoxy. The feed gas for this study was industrial purity helium, which was injected into the quartz tube with a 0.2 L/min gas flow rate. Longer tube (60 mm) is needed to access deeper tumors in brain and breast. In this study, we are accessing effect of length to understand limitation of depth.
In this study, we are assessing the effect of tube length to understand limitation of depth. For instance, it is believed that a longer tube (60 mm) is needed to access deeper tumors in brain and XTT solution was used to determine the relative concentration of superoxide (O 2 -). Superoxide radical reduced soluble formazans of the tetrazolium dye XTT 32, 33 . Fig. 5a and 5b shows the The direct plasma jet irradiation is limited to the skin and it can also be invoked as a supplement therapy during surgery as it only causes cell death in the upper three to five cell layers. However, Thus, we developed a micro-sized plasma devices with 20 mm and 60 mm length stainless steel tubes, which both can achieve effective killing of brain and breast cancer cells. This preliminary study offers significant potential for new treatment applications. Numerous studies reported plasma-induced apoptosis in cancer cells due to plasma-generated various reactive species 1, 36, 37 .
Plasma 5a and 5b). O 2 -can activate mitochondrial-mediated apoptosis by changing mitochondrial membrane potential and simultaneously up-regulates pro-apoptotic genes and down-regulates antiapoptotic genes for activation of caspases resulting in cell death 39 . Fig. 5c Several methods are now being used for the cancer treatment such as chemotherapy, surgery, and radiotherapy [42] [43] [44] . The conventional methods have some disadvantages such as low rapidity, high cost, and adverse effects. However, plasma treatment may overcome these disadvantages of the traditional treatments. Currently, plasma can be directly applied to skin cancers, while it is not applicable for more systemic cancer treatment. However, we developed novel µCAP with 20 mm and 60 mm length can be considered as a local treatment tool and does not exert the systemic therapeutic effects like chemical drugs, meanwhile removing limits of plasma itself. Overall, the above results and discussion indicate that both µCAP with 20 mm and 60 mm length might be useful and should be considered in a clinical medical application.
Conclusions
In this work, we showed that the newly developed micro-sized cold atmospheric plasma ( 
